Expanded Access to Investigational Drugs: What Physicians and the Public Need to Know about FDA and Corporate Processe Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, December 03, 2015

Expanded Access to Investigational Drugs: What Physicians and the Public Need to Know about FDA and Corporate Processe



Article American Medical Association Journal of Ethics December 2015

Author: Paige E. Finkelstein is a second-year medical student in
the University of Miami Miller School of Medicine’s combined MD/MPH program. She is the co-founder of the health care startup ERinfo.me, a patent
-pending mobile application. She received a bachelor of science in chemical engineering and biology from the Massachusetts Institute of Technology in 2014 and hopes to pursue a residency in general surgery followed by a fellowship in surgical oncology.

Related in the
AMA Journal of Ethics

The Terminally Ill, Access to Investigational Drugs, and FDA Rules, August 2013

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.